Site icon OncologyTube

Subgroup analysis of the RECOURSE trial and new information regarding TAS-102 and its effects Annual Meeting GI 2016

Eric Van Cutsem, MD of University of Leuven discusses a subgroup analysis of the RECOURSE trial and new information regarding TAS-102 and its effects at ASCO GI 2016

 

 

 

 

clinical trial, received tas-102, tas-102

Exit mobile version